Full Text
P4 What Can the US Learn from Regulatory Decisions and Health Technology Assessments of New Drugs in Other Countries?

Abstract

Authors

C. Pham K. Le M. Draves Seoane-Vazquez. E

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×